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Abstract
In this paper we analyse a stochastic model representing HIV internal virus dynamics. The stochasticity in the model is in-
troduced by parameter perturbation which is a standard technique in stochastic population modelling. We show that the model
established in this paper possesses non-negative solutions as this is essential in any population dynamics model. We also carry out
analysis on the asymptotic behaviour of the model. We approximate one of the variables by a mean reverting process and find out
the mean and variance of this process. Numerical simulations conclude the paper.
© 2007 Elsevier Inc. All rights reserved.
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1. Introduction
Since its discovery in 1981, HIV has spread relentlessly throughout the world and now is a major epidemic world-
wide. HIV spreads by attacking the immune system, in particular by depleting the CD4 cells. The pathogenesis of
HIV infection is a function of the virus life cycle, the host cellular environment, and quantity of virus in the infected
individual. Factors such as age or genetic differences among individuals, the level of virulence of an individual strain
of virus, and co-infection with other microbes may influence the rate and severity of disease progression.
Cells with CD4 receptors at the site of HIV entry become infected and viral replication begins within them. The
infected cells can then release virions or infected cells can undergo lysis to release new virions, which can then infect
additional cells. CD4 cells, the primary targets of HIV, become infected as they encounter HIV. Active replication
of HIV occurs at all stages of the infection. Over a period of years, even when little virus is detectable in the blood,
significant amounts of virus accumulate within infected cells. This interaction between the virus and the immune
system is called HIV internal viral dynamics. In this paper we will formulate a stochastic model for this host virus
interaction.
Modelling the interaction between HIV-1 virus and CD4 cells has been a major area of research for many years
[4,10,11]. Mathematical models have come to play an important part in biological systems. Mathematics makes it
possible to make predictions about the behaviour of the system. We try to obtain some analytical results for the
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the limit process.
There are real benefits to be gained in using stochastic rather than deterministic models. Real life is stochastic rather
than deterministic, particularly when modelling biological phenomena such as internal HIV viral dynamics. This is
because different cells and infective virus particles reacting in the same environment can often give different results.
In this paper we model the effect of environmental stochasticity on some of the model parameters. Stochastic models
produce more useful output than deterministic models as by running a stochastic model many times we can build up a
distribution of the predicted outcomes, for example the number of infected cells at time t , whilst a deterministic model
will just give a single predicted value. Having a distribution for the predicted outcomes is more versatile as it helps
us examine practically important essentially stochastic quantities, for example the variance of the number of infective
virus particles at a given time and the probability that the infective virus particles have died out at a given time, which
cannot be examined using deterministic models. Even quantities such as the expected values of the number of cells
can be more accurately modelled using stochastic models because they include the effect of random variation on these
quantities which deterministic models cannot.
Other work by Dalal, Greenhalgh and Mao [9] introduces stochasticity into a model of AIDS and condom use
via the technique of parameter perturbation which is standard in stochastic population modelling. They show that the
model established in the paper possesses non-negative solutions as desired in any population dynamics. They also
carried out a detailed analysis on asymptotic stability both in probability one and in pth moment. Our results reveal
that a certain type of stochastic perturbation may help stabilise the system.
Abell, Braselton and Braselton [1] incorporate basic genetics into an AIDS model. They illustrate that if a homozy-
gote is immune to the disease or resistant to the disease, the corresponding allele goes to fixation. On the other hand
if the heterozygote is immune to the disease or is resistant to the effects of the disease, polymorphism usually occurs.
Li and Ma [16] study asymptotic properties of an HIV-1 infection model with a time delay. Based on some important
biological meanings, a class of more general HIV-1 infection models with a time delay is proposed in the paper. In
the HIV-1 infection model a time delay is used to describe the time between infection of uninfected target cells and
the emission of viral particles as proposed by Herz et al. [14]. Then the effect of time delay on the stability of the
equilibria of the HIV-1 infection model has been studied and sufficient criteria for the local asymptotic stability of the
infected equilibrium and global asymptotic stability of the viral-free equilibrium are given.
Many mathematical models have been developed to describe the viral dynamics of HIV-1, mostly using a system
of ordinary differential equations. Perelson et al. [24] tried to estimate the length of the life cycle of the virus. Korthals
Altes et al. [15] concentrated on the question of whether it was advisable to stimulate CD4 cell response. They found
that only when the virus has a low basic reproductive number does the number of CD4 cells at the moment of infection
influence the outcome of infection. Di Mascio et al. [10] provided a statistical characterisation of transient viraemia
observed in 123 patients, suggesting that patients have different tendencies to show transient viraemia during the
period of viral load suppression. Ding and Wu [11] modelled the effect of Reverse Transcriptase Inhibitor drugs as
inhibition rates of cell infection and Protease Inhibitor drugs as inhibition rates of infectious virus production based
on the biological mechanisms of these two different types of drugs. They showed that the two viral decay rates are
monotone functions of the treatment effects of these antiviral therapies.
We start the paper by proving the positivity of the solutions which is a very important property for any model on
population dynamics which uses stochastic differential equations. We then focus on the stability aspect of the three
variables in question. We show that under certain conditions the number of infected cells and virus particles will both
almost surely tend to zero (their disease free equilibrium value). We introduce a mean reverting process and show
that the number of healthy cells tends in probability to this mean reverting process. Hence the number of healthy cells
is stable in distribution. We then give details of the parameters of the mean reverting process. Finally we present a
section on simulations of the system and end the paper with our conclusions.
2. Deterministic model
This process of HIV-1 pathogenesis can be slowed down or reversed to a certain extent by Highly Active Antiretro-
viral Treatment (HAART). Primarily HAART inhibits the process of virus particle formation. This keeps the viral
load down and in turn increases the quantity of CD4 cells. The model we are going to study is a stochastic model of
viral dynamics including the effect of HAART.
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different factors associated with resurgence. They first gave a nonlinear model of HIV-1 dynamics, then included drug
exposure, compliance to treatment and insurgence of resistant HIV-1 strains. They also showed the application of the
models using real AIDS clinical trial data involving patients treated with a combination of antiretroviral drugs.
Nelson and Perelson [21] were of the opinion that models that include intracellular delays are more accurate rep-
resentations of the biology and change the estimated values of kinetic parameters when compared to models without
delays. They developed and analysed a set of models that included intracellular delays, combination antiretroviral
therapy, and the dynamics of both infected and uninfected T cells. They showed that for less than perfect drug effect,
the value of the death rate of productively infected cells is increased when data is fitted with delay models compared
to the values estimated with a non-delay model. They also provided some general results on the stability of the system.
Very recently Ciupe et al. [7] discussed the dynamics of HIV-1 infection consisting of three distinct phases starting
with primary infection, then latency and finally AIDS or drug therapy. In this paper the dynamics of primary infection
and the beginning of latency was modelled. They showed that allowing for time delays in the model better predicts
viral load data when compared to models with no time delays. They also found that the model of primary infection
predicts the turnover rates for productively infected T cells and viral totals to be much longer than those observed
from patients receiving antiviral drug therapy. However, they also showed that with the data available the results are
highly sensitive to the chosen model. They compared the results using analysis and Monte Carlo techniques for three
different models and showed how each predicts rather dramatic differences between the fitted parameters.
We propose the following three-dimensional model to describe the viral dynamics in the presence of HIV-1 infec-
tion and HAART:
dx1(t)
dt
= λ − δx1(t) − (1 − γ )βx1(t)x3(t),
dx2(t)
dt
= (1 − γ )βx1(t)x3(t) − ax2(t),
and
dx3(t)
dt
= (1 − η)Nax2(t) − ux3(t) − (1 − γ )βx1(t)x3(t)
with suitable initial conditions. This model captures mathematically the viral dynamics of HIV-1 virus interacting
with CD4 cells. The model is represented diagrammatically by Fig. 1.
HAART is generally a combination of reverse transcriptase inhibitor (RTI) drugs and protease inhibitor (PI) drugs.
RTI drugs are designed to prevent the conversion of HIV RNA to DNA in early stages of HIV replication. Thus RTI
drugs block conversion of uninfected cells to infected cells. PI drugs are designed to intervene in the last stage of the
virus replication cycle to prevent HIV from being properly assembled, and thus cause the newly produced virus to be
noninfectious [11]. The variables and parameters in the model are described as follows:
Fig. 1. Box diagram representing cell and virus dynamics.
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x2(t) is the concentration of infected cells;
x3(t) is the concentration of virus particles;
(1 − γ ) is the reverse transcriptase inhibitor drug effect;
(1 − η) is the protease inhibitor drug effect;
λ is the total rate of production of healthy cells per unit time;
δ is the per capita death rate of healthy cells;
β is the transmission coefficient between uninfected cells and infective virus particles;
a is the per capita death rate of infected cells;
N is the average number of infective virus particles produced by an infected cell in
the absence of HAART during its entire infectious lifetime;
u is the per capita death rate of infective virus particles.
Note that when a single infective virus particle infects a single uninfected cell the virus particle is absorbed into
the uninfected cell and effectively dies. Hence the term (1 − γ )βx1x3 appears in all the three equations. It is clear
that the above model has a unique disease-free equilibrium given by (λ/δ1,0,0). Each newly infected cell entering
the disease-free equilibrium remains infected for time (1/a) and during this time produces (1 − η)N infective virus
particles. As an approximation assuming that the system is still near the disease-free equilibrium each infective virus
particle survives for time (u + (1 − γ )βλ/δ) and during this time infects
(1 − γ )β λ
δ
(u + (1 − γ )β λ
δ
)
= (1 − γ )βλ
δu + (1 − γ )βλ
cells. R0, the basic reproduction number, is defined as the expected number of secondary infected cells caused by a
single infected cell entering the disease-free population at equilibrium. Here a secondary infected cell is a cell which
is infected by an infective virus particle which is produced by the initial infected cell. Hence
R0 = (1 − γ )βλN(1 − η)
(δu + βλ(1 − γ )) .
R0 can also be interpreted as the expected number of secondary infected virus particles caused by a single infected
virus particle entering the disease-free population at equilibrium. Here a secondary infective virus particle is an infec-
tive virus particle produced by an infected cell which was infected by the original infective virus particle. We obtain
the same expression for R0.
The deterministic model has been analysed by Tuckwell and Wan [26]. They show that if R0  1 then the disease-
free equilibrium is the unique equilibrium and if R0 > 1 then as well as the disease-free equilibrium there is a unique
endemic equilibrium given by
x∗1 =
u
β(1 − γ )[N(1 − η) − 1] ,
x∗2 =
βλ(1 − γ )N(1 − η) − βλ(1 − γ )− δu
aβ(1 − γ )(N(1 − η)− 1) ,
x∗3 =
βλ(1 − γ )N(1 − η) − βλ(1 − γ )− δu
(1 − γ )βu .
Moreover if R0 < 1 the disease-free equilibrium is locally asymptotically stable, whilst if R0 > 1 then the disease-
free equilibrium is unstable whilst the unique endemic equilibrium is locally asymptotically stable. Thus if R0 < 1
we expect the number of infected cells and infected virus particles to die out and the number of uninfected cells to
approach λ/δ, whilst if R0 > 1 we expect the number of uninfected cells, infected cells and infective virus particles
to approach their unique endemic equilibrium values.
Perelson et al. [24] studied a simplified version of our deterministic model. They assume that the number of
uninfected cells is constant. They later introduce drug treatment and fit the model to data. Bonhoeffer et al. [4] analyse
a simplified version of our deterministic model where the term (1 − γ )βx1(t)x3(t) is neglected as an approximation.
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the behaviour of the system. For R0  1 there is a unique disease-free equilibrium which is locally asymptotically
stable but for R0 > 1 there is a unique endemic equilibrium. They later modify the basic model to include the effect
of resistance. Di Mascio et al. [10] take the simple deterministic model of Bonhoeffer et al. and modify it to introduce
the effect of HAART in a similar way as we have done. They later discuss another model and fitting their models to
data. Nelson and Perelson [21] outline the basic model discussed by Bonhoeffer et al. [4]. They discuss modification
of this basic model to summarize the effects of drug therapy on virus concentration and introduce a time delay into
the model. The model is then fitted to data.
All of the above models are deterministic models and do not introduce stochastic effects. The other models dis-
cussed in our literature review such as Ding and Wu [11], Korthals Altes et al. [15], Ciupe et al. [7] and Verotta and
Schaedeli [27] have similarities with our model but introduce extra or different variables such as two types of infected
cells, two types of infective virus particles or CD8 cells.
3. Stochastic model derivation
There are a range of mechanisms through which CD4 cell death takes place. This includes syncytium formation
and apoptosis among other things [20]. The clearance rate of virions can be caused by a variety of factors including
binding and entry into cells and immune elimination [24]. Since both the death rates of the cells and the virus are
affected by many complicated biological phenomena we think that there is randomness involved in these death rates.
For a number of years, many scientists have believed that HIV depletes its primary target, CD4+ T cells, by blocking
new T-cell production. On the other hand some studies have challenged that point of view, showing that HIV does not
block such production but instead accelerates the division of existing T cells. Following the initiation of highly active
antiretroviral therapy, or HAART, there is an immediate drop in the rate of T-cell production accompanied by an even
greater decrease in the rate of CD4 T-cell death. Thus, the increases in CD4+ T-cell counts seen following HAART
are not due to a boost in the production of new T cells. Rather, they are caused by a slowdown in the loss of existing T
cells. This contradictory view gives us reason to believe that we can input randomness in the death rates of CD4 cells.
Taking these factors into account we introduce randomness into the model by replacing the parameters δ, a and u
by δ → δ + σ1B˙1(t), a → a + σ1B˙1(t) and u → u+ σ2B˙2(t). This is only a first step in introducing stochasticity into
the model. Ideally we would also like to introduce stochastic environmental variation into the other parameters such
as the transmission coefficient β and λ, the total rate of production of healthy cells per unit time, but to do this would
make the analysis much too difficult.
Hence we get the following system of stochastic differential equations:
dx1(t) =
(
λ − δx1(t) − (1 − γ )βx1(t)x3(t)
)
dt − σ1x1(t) dB1(t), (1)
dx2(t) =
(
(1 − γ )βx1(t)x3(t) − ax2(t)
)
dt − σ1x2(t) dB1(t), (2)
and
dx3(t) =
(
(1 − η)Nax2(t) − ux3(t) − (1 − γ )βx1(t)x3(t)
)
dt − σ2x3(t) dB2(t) (3)
with suitable initial conditions.
Here B1(t) and B2(t) are independent standard Brownian motions. When there is randomness in parameters such
as the disease death rate it is a standard technique to introduce environmental noise into the parameters in this way
[3,5,13,18,19]. Note that the intensity of the noise σ and the Brownian motion B(t) are the same for uninfected
and infected CD4 cells, but different for CD4 cells and virus particles. This is because whilst the biological factors
affecting the death rates of infected and uninfected CD4 cells can be expected to be very similar, different biological
factors affect CD4 cells and virus particles.
Hence although in the absence of detailed biological data it is possible that the intensity of the noise σ and the
Brownian motion B(t) are different for uninfected and infected CD4 cells it is plausible as a first simplifying approxi-
mation to assume that these are the same. As CD4 cells and virus particles are much more different biological entities
it seems much more possible that both σ and B(t) are different between CD4 cells and infective virus particles.
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(x1, x2, x3) = (λ/δ,0,0)
is an equilibrium point in the deterministic model but not for the stochastic model. In the stochastic model the last two
co-ordinates (x2, x3) = (0,0) are still a stochastic equilibrium, but the situation is changed for the first co-ordinate of
the process which we shall see later varies stochastically around the value λ/δ.
4. Non-negative solutions
It is important that we do not have to worry about negative values when dealing with a model of population
dynamics is concerned. Hence we first prove the positivity of the solutions.
In this paper, unless otherwise specified, we let (Ω,F ,P ) be a complete probability space with a filtration {Ft }t0
satisfying the usual conditions (i.e. it is increasing and right continuous while F0 contains all P -null sets). Let B(t) be
the one-dimensional Brownian motion defined on this probability space. Also let R3++ = {x ∈ R3: xi > 0 for all 1
i  3} and let x(t) = (x1(t), x2(t), x3(t)).
Before proving the main theorem we put forward a lemma.
Lemma 4.1. The following inequality holds
u 2
(
u + 1 − log(u))− (4 − 2 log 2), ∀u > 0.
Proof. Define, for u > 0,
f (u) = u + 2 − 2 log(u).
f (u) has a minimum at u = 2. The result follows. 
We now prove the main theorem.
Theorem 4.1. Assume that 0 < γ , η < 1 and that δ, λ, a, u, N and β are positive real numbers. Then for any initial
value x0 ∈ R3++, there is a unique solution x(t) to Eqs. (1)–(3) on t  0 and the solution will remain in R3++ with
probability 1, namely x(t) ∈ R3++ for all t  0 almost surely.
Proof. Since the coefficients of the equation are locally Lipschitz continuous, for any given initial value x0 ∈ R3++
there is a unique local solution x(t) on t ∈ [0, τe), where τe is the explosion time [2,12]. To show this solution is
global, we need to show that τe = ∞ a.s. Let k0  0 be sufficiently large so that every component of x0 lies within the
interval [1/k0, k0]. For each integer k  k0, define the stopping time
τk = inf
{
t ∈ [0, τe): xi(t) /∈ (1/k, k) for some i, 1 i  3
}
,
where throughout this paper we set inf∅ = ∞ (as usual ∅ denotes the empty set). Clearly, τk is increasing as k → ∞.
Set τ∞ = limk→∞ τk , whence τ∞  τe a.s. If we can show that τ∞ = ∞ a.s. then τe = ∞ and x(t) ∈ R3++ a.s. for all
t  0. In other words, to complete the proof all we need to show is that τ∞ = ∞ a.s. For if this statement is false, then
there is a pair of constants T > 0 and 
 ∈ (0,1) such that
P {τ∞  T } > 
.
Hence there is an integer k1  k0 such that
P {τk  T } 
 for all k  k1. (4)
Define a C2-function V : R3++ → R++ by
V (x) =
3∑
i=1
[
xi + 1 − log(xi)
]
.
The non-negativity of this function can be seen from u + 1 − log(u) 0, ∀u > 0. Using Itô’s formula we get
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(
x(t)
)= [(1 − 1
x1(t)
)(
λ − δx1(t) − (1 − γ )βx1(t)x3(t)
)+(1 − 1
x2(t)
)(
(1 − γ )βx1(t)x3(t) − ax2(t)
)
+
(
1 − 1
x3(t)
)(
(1 − η)Nax2(t) − ux3(t) − (1 − γ )βx1(t)x3(t)
)+ σ 21 + σ 222
]
dt
+ σ1
(
2 − x1(t) − x2(t)
)
dB1(t) + σ2
(
1 − x3(t)
)
dB2(t)
=
[
λ − δx1(t) − (1 − γ )βx1(t)x3(t) + (1 − γ )βx1(t)x3(t) − ax2(t) + (1 − η)Nax2(t) − ux3(t)
− (1 − γ )βx1(t)x3(t) − λ
x1(t)
+ δ + (1 − γ )βx3(t) − (1 − γ )
x2(t)
βx1(t)x3(t) + a
− (1 − η)Nax2(t)
x3(t)
+ u + (1 − γ )βx1(t) + σ 21 +
σ 22
2
]
dt + σ1
(
2 − x1(t) − x2(t)
)
dB1(t)
+ σ2
(
1 − x3(t)
)
dB2(t).
Hence
dV
(
x(t)
)

[
λ + δ + a + u + σ 21 +
σ 22
2
+ (1 − η)Nax2(t) + (1 − γ )βx3(t) + (1 − γ )βx1(t)
]
dt
+ σ1
(
2 − x1(t) − x2(t)
)
dB1(t) + σ2
(
1 − x3(t)
)
dB2(t).
Write
c1 = λ + δ + a + u + σ 21 +
σ 22
2
and c2 = 2(1 − η)Na + 2(1 − γ )β.
By Lemma 4.1, xi  2(xi +1− log(xi)) so (1−η)Nax2(t)+ (1−γ )βx3(t)+ (1−γ )βx2(t) c2V (x). Therefore
dV
(
x(t)
)

(
c1 + c2V (x)
)
dt + σ1
(
2 − x1(t) − x2(t)
)
dB1(t) + σ2
(
1 − x3(t)
)
dB2(t).
Hence
dV
(
x(t)
)
 c3
(
1 + V (x))+ σ1(2 − x1(t) − x2(t))dB1(t) + σ2(1 − x3(t))dB2(t)
where c3 = max(c1, c2). Therefore if t1  T ,
τk∧t1∫
0
dV
(
x(t)
)

τk∧t1∫
0
c3
(
1 + V (x(t)))dt +
τk∧t1∫
0
σ1
(
2 − x1(t) − x2(t)
)
dB1(t) +
τk∧t1∫
0
σ2
(
1 − x3(t)
)
dB2(t).
This implies that
EV
(
x(τk ∧ t1)
)
 V (x0) + E
τk∧t1∫
0
c3
(
1 + V (x(t)))dt  V (x0) + c3t1 + c3E
τk∧t1∫
0
V
(
x(t)
)
dt
 V (x0) + c3T + c3E
t1∫
0
V
(
x(τk ∧ t)
)
dt = V (x0) + c3T + c3
t1∫
0
EV
(
x(τk ∧ t)
)
dt.
By the Gronwall inequality,
EV
(
x(τk ∧ T )
)
 c4 (5)
where c4 = (V (x0) + c3T )ec3T . 
Set Ωk = {τk  T } for k  k1 and by (4), P(Ωk) 
. Note that for every ω ∈ Ωk , there is some i (1  i  3) such
that xi(τk,ω) equals either k or 1/k, and hence V (x(τk,ω)) is no less than the smallest of
k + 1 − log(k) and (1/k) + 1 − log(1/k) = (1/k) + 1 + log(k).
N. Dalal et al. / J. Math. Anal. Appl. 341 (2008) 1084–1101 1091Consequently,
V
(
x(τk,ω)
)

[
k + 1 − log(k)]∧ [(1/k) + 1 + log(k)].
It then follows from (4) and (5) that
c4 E
[
1Ωk(ω)V
(
x(τk,ω)
)]
 

([
k + 1 − log(k)]∧ [(1/k) + 1 + log(k)]),
where 1Ωk is the indicator function of Ωk . Letting k → ∞ leads to the contradiction ∞ > c4 = ∞. So we must
therefore have τ∞ = ∞ a.s.
In the next section we look at the asymptotic behaviour of the system and try to obtain some more analytical results.
5. Asymptotic behaviour
For the deterministic system the disease free equilibrium is (λ/δ,0,0). Recall that this is not an equilibrium point
for the stochastic model where (x2, x3) = (0,0) is still a stochastic equilibrium but the first co-ordinate instead of
being fixed at λ/δ follows a stochastic process which varies around the value λ/δ. First we consider x2(t), x3(t) and
find the conditions for exponential stability. Then we obtain the stability in distribution of x1(t).
Definition 5.1. (See [17, p. 119].) Let (Ω,F ,P ) be a complete probability space with a filtration {Ft }t0 which is
right continuous and F0 contains all P -null sets.
Suppose that 0 t0 < T < ∞. Let x0 be an Ft0 -measurable Rd -valued random variable such that E|x0|2 < ∞. Let
f : Rd × [t0, T ] → Rd and g : Rd × [t0, T ] → Rd×m be both Borel measurable with f (0, t) = 0 and g(0, t) = 0 for
all t  t0. Consider the d-dimensional stochastic differential equation of Itô-type
dx(t) = f (x(t), t)dt + g(x(t), t)dB(t) (6)
on t0  t  T , with initial value x(t0) = x0. Write x(t; t0, x0) for the value of the solution to this equation at time t .
The trivial solution of Eq. (6) is said to be almost surely exponentially stable if
lim
t→∞ sup
1
t
log
∣∣x(t; t0, x0)∣∣< 0 a.s.
for all x0 ∈ Rd.
Theorem 5.1. Under the following two conditions:
(i) 2[(1 − η)Na − a] − σ 21 < 0;
(ii) [((1 − η)Na − a)− u]2 < (σ 22 + 2u)(σ 21 − 2[(1 − η)Na − a]);
x2(t) and x3(t) are almost surely exponentially stable in the sense that x2(t) and x3(t) will tend to their equilibrium
value 0 exponentially with probability 1.
Proof. From Eqs. (2) and (3) consider d(x2(t) + x3(t)),
d
(
x2(t) + x3(t)
)= ((1 − γ )βx1(t)x3(t) − ax2(t) + (1 − η)Nax2(t) − ux3(t) − (1 − γ )βx1(t)x3(t))dt
− σ1x2(t) dB1(t) − σ2x3(t) dB2(t).
Let x = (x2, x3) and V (x) = log(x2 + x3) for x2, x3 ∈ (0,∞). Using Itô’s formula we get
dV
(
x(t)
)= ( (1 − η)Nax2(t)
x2(t) + x3(t) −
ax2(t)
x2(t) + x3(t) −
ux3(t)
x2(t) + x3(t) −
1
2
σ 21 x
2
2(t)
(x2(t) + x3(t))2 −
1
2
σ 22 x
2
3(t)
(x2(t) + x3(t))2
)
dt
− σ1x2(t)
(x2(t) + x3(t)) dB1(t) −
σ2x3(t)
(x2(t) + x3(t)) dB2(t).
Simplifying we get
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(
x(t)
)= 1
2(x2(t) + x3(t))2
(
2
(
x2(t) + x3(t)
)(
(1 − η)Nax2(t) − ax2(t) − ux3(t)
)− σ 21 x22(t) − σ 22 x23(t))dt
− σ1x2(t)
(x2(t) + x3(t)) dB1(t) −
σ2x3(t)
(x2(t) + x3(t)) dB2(t).
We can write the term(
2
(
x2(t) + x3(t)
)(
(1 − η)Nax2(t) − ax2(t) − ux3(t)
)− σ 21 x22(t) − σ 22 x23(t))
in the following way
(
x2(t) x3(t)
)( 2((1 − η)Na − a) − σ 21 ((1 − η)Na − a) − u
((1 − η)Na − a) − u −2u − σ 22
)(
x2(t)
x3(t)
)
.
Hence we can write dV (x(t)) as
dV
(
x(t)
)
= 1
2(x2(t) + x3(t))2
{(
x2(t) x3(t)
)( 2((1 − η)Na − a)− σ 21 ((1 − η)Na − a) − u
((1 − η)Na − a) − u −2u − σ 22
)(
x2(t)
x3(t)
)}
dt
− σ1x2(t)
(x2(t) + x3(t)) dB1(t) −
σ2x3(t)
(x2(t) + x3(t)) dB2(t).
Now consider the matrix(
2((1 − η)Na − a) − σ 21 ((1 − η)Na − a)− u
((1 − η)Na − a) − u −2u − σ 22
)
.
As the above matrix is negative-definite with largest (negative) eigenvalue λmax then
(
x2(t) x3(t)
)( 2((1 − η)Na − a) − σ 21 2((1 − η)Na − a)− u
2((1 − η)Na − a) − u −2u − σ 22
)(
x2(t)
x3(t)
)
 λmax
(
x22(t) + x23(t)
)= −|λmax|(x22(t) + x23(t)).
Therefore
dV
(
x(t)
)

(
−|λmax| 12(x2(t) + x3(t))2
(
x22(t) + x23(t)
))
dt
− σ1x2(t)
(x2(t) + x3(t)) dB1(t) −
σ2x3(t)
(x2(t) + x3(t)) dB2(t). (7)
As 0.5(x22 + x23) x2x3 we can write −(x22 + x23)−0.5(x2 + x3)2.
Substituting this in inequality (7) we get
dV
(
x(t)
)
−1
4
|λmax|dt − σ1x2(t)
(x2(t) + x3(t)) dB1(t) −
σ2x3(t)
(x2(t) + x3(t)) dB2(t),
d
(
log
(
x2(t) + x3(t)
))
−1
4
|λmax|dt − σ1x2(t)
(x2(t) + x3(t)) dB1(t) −
σ2x3(t)
(x2(t) + x3(t)) dB2(t).
Integrating the above inequality and using the fact that
lim sup
t→∞
1
t
∣∣Bi(t)∣∣= 0 for i = 1,2 (Mao [17]),
we get
lim sup
t→∞
1
t
log
(
x2(t) + x3(t)
)
−1
4
|λmax| < 0 a.s.
Hence x2(t) → 0 and x3(t) → 0 a.s. as t → ∞. This completes the proof of Theorem 5.1. 
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that the conditions of Theorem 5.1 cannot possibly be satisfied in the deterministic model when σ1 = σ2 = 0.
The constraints on the variances in Theorem 5.1(i) and (ii) have no obvious biological meaning in themselves.
However note that the expression (1 − η)Na is the per capita rate at which an infected cell produces virus particles
in the presence of HAART. Under the condition (1 − η)N < 1, i.e. an infected cell produces on average less than
one infective virus particle during its entire infectious lifetime, which implies that R0 < 1, the first condition in
Theorem 5.1 will always be true. If the variances σ 21 and σ 22 are large enough these conditions will always be satisfied.
This is an interesting result as it says that if the noise variances are large enough then the populations of infected
cells and infective virus particles will always die out, whatever the other parameter values, even if R0 > 1. Thus the
behaviour of the stochastic system with added environmental noise can be very different than the behaviour of the
basic deterministic system.
We now concentrate on x1(t). We shall eventually show that x1(t) is stable in distribution in the sense that it
stabilises around the mean value λ/δ. To do this we introduce a new stochastic process z(t) which is defined by its
initial condition z(0) = x1(0) and the stochastic differential equation
dz(t) = (λ − δz(t))dt − σ1z(t) dB1(t).
We shall show that in the limit as t becomes large x1(t) can be approximated by z(t) so
lim
t→∞
(
z(t) − x1(t)
)= 0 in probability.
To help with the proof we introduce another function y
(t) which is defined by the initial condition y
(0) = x1(0) and
the stochastic differential equation
dy
(t) =
(
λ − (δ + 
)y
(t)
)
dt − σ1y
(t) dB1(t). (8)
Theorem 5.2. Under the conditions of Theorem 5.1,
lim
t→∞
(
z(t) − x1(t)
)= 0 in probability.
Proof. The original equation is
dx1(t) =
(
λ − δx1(t) − (1 − γ )βx1(t)x3(t)
)
dt − σ1x1(t) dB1(t).
First we prove that
lim inf
t→∞
(
x1(t) − y
(t)
)
 0 a.s.
Therefore consider
d
(
x1(t) − y
(t)
)= (−δ(x1(t) − y
(t))+ 
y
(t) − (1 − γ )βx1(t)x3(t))dt − σ1(x1(t) − y
(t))dB1(t)
= (−(δ + 
)(x1(t) − y
(t))+ (
 − (1 − γ )βx3(t))x1(t))dt − σ1(x1(t) − y
(t))dB1(t).
The solution is given by
x1(t) − y
(t) = ψ(t)
t∫
0
ψ−1(s)
(

 − (1 − γ )βx3(s)
)
x1(s) ds
where
ψ(t) = exp
{
−
(
δ + 
 + σ
2
1
2
)
t − σ1B1(t)
}
.
Using the result of Theorem 5.1 where it has been shown that x3(t) → 0 a.s. as t → ∞ we can write, for almost
all ω ∈ Ω , ∃T = T (ω) such that
x3(t) <


, ∀t  T .
(1 − γ )β
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x1(t) − y
(t) = ψ(t)
( T∫
0
ψ−1(s)
(

 − (1 − γ )βx3(s)
)
x1(s) ds +
t∫
T
ψ−1(s)
(

 − (1 − γ )βx3(s)
)
x1(s) ds
)
.
Hence x1(t) − y
(t)ψ(t)κ(T ) where
κ(T ) =
T∫
0
ψ−1(s)
(

 − (1 − γ )βx3(s)
)
x1(s) ds.
Clearly |κ(T )| < ∞ and ψ(t) → 0 a.s.
Therefore
lim inf
t→∞
(
x1(t) − y
(t)
)
 0 a.s. (9)
Next we prove lim inft→∞(z(t) − x1(t)) 0 a.s. For this consider
d
(
z(t) − x1(t)
)= (−δ(z(t) − x1(t))+ (1 − γ )βx1(t)x3(t))dt − σ1(z(t) − x1(t))dB1(t).
This implies that
d
(
z(t) − x1(t)
)
−δ(z(t) − x1(t))dt − σ1(z(t) − x1(t))dB1(t).
Let ξ = z − x1. Hence
dξ(t)−δξ(t) dt − σ1ξ(t) dB1(t).
For any ω ∈ Ω either
ω ∈ Ω1 =
{
ω: ξ(t0) > 0 for some t0  0
}
or
ω ∈ Ω2 =
{
ω: ξ(t) 0 for all t  0
}
.
For ω ∈ Ω1 then let t1 = sup{t : t  t0 and ξ(t) > 0}. If t1 < ∞ then in [t0, t1]
dξ(t) = (−δ + f (t))ξ(t) dt − σ1ξ(t) dB1(t) (10)
where f (t) 0 is a random variable. The solution of (10) is given by
ξ(t) = ξ(t0) exp
{ t∫
0
(
−δ + f (s) − σ
2
1
2
)
ds − σ1B1(t)
}
> 0.
Hence
ξ(t1) = ξ(t0) exp
{ t1∫
t0
(
−δ + f (s) − σ
2
1
2
)
ds − σ1B1(s)
}
> 0.
Thus ξ(t) > 0 in [t1, t1 + δ1] for some δ1 > 0. This is a contradiction. Hence t1 = ∞ and ξ(t) 0 for all t  t0. So
lim inft→∞ ξ(t) 0 a.s.
It remains to consider the case ω ∈ Ω2 where ξ(t) 0 for all t  0. Then
dξ(t) = (−δ − f (t))ξ(t) dt − σ1ξ(t) dB1(t) (11)
where f (t) 0 is a random variable. The solution of (11) is given by
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{ t∫
0
(
−δ − f (s) − σ
2
1
2
)
ds − σ1B1(t)
}
= 0.
Hence lim inft→∞ ξ(t) 0 a.s. That is
lim inf
t→∞
(
z(t) − x1(t)
)
 0 a.s. (12)
Next consider d(y
(t) − z(t)),
d
(
y
(t) − z(t)
)= (−δ(y
(t) − z(t))− 
y
(t))dt − σ1(y
(t) − z(t))dB1(t).
The solution is written as
y
(t) − z(t) = −
 exp
{
−
(
δ + σ
2
1
2
)
t − σ1B1(t)
} t∫
0
exp
{(
δ + σ
2
1
2
)
s + σ1B1(s)
}
y
(s) ds.
Note that y
(s) 0 as it is a solution of a linear stochastic differential equation (8) which can be solved explicitly to
give
y
(t) = λ
t∫
0
exp
{
−
(
δ + 
 + σ
2
1
2
)
(t − s) − σ1
(
B1(t) − B1(s)
)}
ds. (13)
Therefore
∣∣y
(t) − z(t)∣∣= 

t∫
0
y
(s) exp
{
−
(
δ + σ
2
1
2
)
(t − s) − σ1
(
B1(t) − B1(s)
)}
ds.
Since B1(t) − B1(s) ∼ N(0, t − s) we write
E
[
exp
[−σ1(B1(t) − B1(s))]]=
∞∫
−∞
e−σ1u 1√
2π(t − s)e
−u2/2(t−s) du
= 1√
2π(t − s)
∞∫
−∞
exp
{ −1
2(t − s)
(
u2 + 2(t − s)σ1u
)}
du
= 1√
2π(t − s) exp
{
σ 21 (t − s)
2
} ∞∫
−∞
exp
{ −1
2(t − s)
{
u + (t − s)σ1
}2}
du.
Hence
E
[
exp
[−σ1(B1(t) − B1(s))]]= exp
{
σ 21 (t − s)
2
}
. (14)
Therefore
E
∣∣y
(t) − z(t)∣∣= 
E
[ t∫
0
y
(s) exp
{
−
(
δ + σ
2
1
2
)
(t − s) − σ1
(
B1(t) − B1(s)
)}
ds
]
= 

t∫
0
E
[
y
(s) exp
{
−
(
δ + σ
2
1
2
)
(t − s) − σ1
(
B1(t) − B1(s)
)}
ds
]
= 

t∫
0
E
[
y
(s) exp
{
−
(
δ + σ
2
1
2
)
(t − s)
}]
E
[
exp
[−σ1(B1(t) − B1(s))]]ds
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= 

t∫
0
exp
{−δ(t − s)}Ey
(s) ds, using (14). (15)
Taking the expectation of (13) and using (14) we see that
Ey
(t) = λ
t∫
0
exp
{−(δ + 
)(t − s)}ds  λ
δ + 
 .
Substituting this result in (15) we get
E
∣∣y
(t) − z(t)∣∣ λ

δ + 

t∫
0
exp
{−δ(t − s)}ds  λ
e−δt
(δ + 
)δ
(
eδt − 1).
Hence we can write
lim

→0 limt→∞E
∣∣y
(t) − z(t)∣∣= 0.
This implies that
lim

→0 limt→∞
∣∣y
(t) − z(t)∣∣= 0 in probability. (16)
Combining (9), (12) and (16) we obtain the required assertion. This completes the proof of Theorem 5.2. 
In the next section we try and obtain some more information about the mean reverting process.
6. Mean reverting process
As we are approximating the process x1(t) by z(t) we wish to find some information about the process z(t). We
try and do that here by finding the parameters of the process such as the mean and the variance.
The mean reverting process is given by
dz(t) = (λ − δz(t))dt − σ1z(t) dB1(t).
The explicit solution of the above equation is given by
z(t) = z(0) exp
{
−
(
δ + σ
2
1
2
)
t − σ1B1(t)
}
+ λ
t∫
0
exp
{
−
(
δ + σ
2
1
2
)
(t − s) − σ1
(
B1(t) − B1(s)
)}
ds.
Taking the expectation and using (14) we get
E
(
z(t)
)= z(0)e−δt + λ
δ
(
1 − e−δt).
Hence taking the limit we get
lim
t→∞E
(
z(t)
)= λ
δ
.
To find the second moment consider V (z(t)) = z2. Using Itô’s formula we get
d
(
z2(t)
)= (σ 21 − 2δ)z2(t) dt + 2λz(t) dt − 2σ1z2(t) dB1(t).
Therefore
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t∫
0
(
σ 21 − 2δ
)
z2(s) ds + 2λ
t∫
0
z(s) ds − 2σ1
t∫
0
z2(s) dB1(s).
Taking expectation we get
E
(
z2(t)
)= E(z2(0))+
t∫
0
(
σ 21 − 2δ
)
E
(
z2(s)
)
ds + 2λ
t∫
0
E
(
z(s)
)
ds.
Differentiating with respect to t we deduce that
d
dt
E
(
z2(t)
)= (σ 21 − 2δ)E(z2(t))+ 2λE(z(t)), ddt
{
E
(
z2(t)e−(σ 21 −2δ)t
)}= 2λE(z(t))e−(σ 21 −2δ)t .
Integrating and multiplying by e(σ 21 −2δ)t we deduce that
E
(
z2(t)
)= E(z2(0))e(σ 21 −2δ)t + 2λe(σ 21 −2δ)t
t∫
0
e−(σ 21 −2δ)sE
(
z(s)
)
ds.
Now substituting the value of E(z(s)) in the above equation we see that
E
(
z2(t)
)= E(z2(0))e(σ 21 −2δ)t + 2λe(σ 21 −2δ)t
{ t∫
0
e−(σ 21 −2δ)s
(
z(0)e−δs + λ
δ
(
1 − e−δs))
}
ds.
Simplifying we get
E
(
z2(t)
)= E(z2(0))e(σ 21 −2δ)t + 2λe(σ 21 −2δ)t
{
z(0)
t∫
0
e−(σ 21 −2δ)se−δs ds + λ
δ
t∫
0
e−(σ 21 −2δ)s
(
1 − e−δs)ds
}
= E(z2(0))e(σ 21 −2δ)t + 2λe(σ 21 −2δ)t{−(z(0) − λδ
σ 21 − δ
)(
e−(σ 21 −δ)t − 1)− λ
δ(σ 21 − 2δ)
(
e−(σ 21 −2δ)t − 1)},
provided that σ 21 = δ,2δ,
= E(z2(0))e(σ 21 −2δ)t − 2λ(z(0) − λδ
σ 21 − δ
)
e−δt + 2λ
(
z(0) − λ
δ
σ 21 − δ
)
e(σ
2
1 −2δ)t − 2λ
2
δ(σ 21 − 2δ)
+ 2λ
2
δ(σ 21 − 2δ)
e(σ
2
1 −2δ)t .
Taking the limit we need σ 21 < 2δ for limt→∞ E(z2(t)) < ∞, when we obtain
lim
t→∞E
(
z2(t)
)= 2λ2
δ(2δ − σ 21 )
.
The above term is positive since σ 21 − 2δ < 0. Hence the asymptotic variance of the mean reverting process is
lim
t→∞V
(
z(t)
)= 2λ2
δ(2δ − σ 21 )
− λ
2
δ2
= λ
2σ 21
δ2(2δ − σ 21 )
.
A similar argument shows that if σ 21 = δ then
lim
t→∞V
(
z(t)
)= λ2
δ2
,
and if σ 2  2δ then limt→∞ V (z(t)) = ∞.1
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2
1 given by
λ2σ 21
δ2(2δ − σ 21 )
whereas if σ 21  2δ then the limit process has infinite variance.
7. Simulations
According to our analytical results the infected cells and the virus particles are both exponentially stable and tend
to zero under conditions specified in Theorem 5.1. Also we see that we can asymptotically approximate x1(t) by z(t)
where z(t) is the mean reverting process. We now try and support our analytical results by simulations. Our simulation
programs have been written in FORTRAN and the results were verified by running them repeatedly and extensively
checking the results.
To illustrate the stochastic effects clearly we performed simulations first for the deterministic case (Fig. 2) and
then for a corresponding stochastic simulation (Fig. 3). The parameter values used have all been taken from published
literature. δ, u, a have been taken from [4], N from [6], β from [23] and λ from [22]. The parameter values for Fig. 2
are β = 1×10−8 day−1 dm3, λ = 106 day−1 dm−3, N = 100 per cell, γ = 0.5, η = 0.5, a = 0.5 day−1, δ = 0.1 day−1
and u = 5 day−1. The initial values were x1(0) = 10000 dm−3, x2(0) = 10000 dm−3 and x3(0) = 10000 dm−3. The
corresponding stochastic simulation (Fig. 3) uses the same parameter and initial values but additionally has σ1 = 0.1
and σ2 = 0.1. It is straightforward to verify that with these parameter values R0 = 0.495 < 1 and that the conditions
of Theorem 5.1 are not satisfied.
As can be clearly seen from Figs. 2 and 3 both x2(t) and x3(t) tend to zero exponentially in both the deterministic
and stochastic models. These simulations and others suggest that when R0 for the deterministic model is less than
one, in the stochastic model both x2(t) and x3(t) tend to zero exponentially even if the conditions of Theorem 5.1 are
not satisfied. Comparing Figs. 2 and 3 one can also see the stochastic effects very clearly.
Fig. 2. HIV in vivo virus dynamics deterministic differential equation model approaches the disease free equilibrium for R0 < 1.
N. Dalal et al. / J. Math. Anal. Appl. 341 (2008) 1084–1101 1099Fig. 3. Stochastic simulation corresponding to Fig. 2.
Fig. 4. Distribution of x1(t) at large time t .
Figures 4 and 5 represent the histograms of the values of x1(t) and z(t), respectively. The parameter values and the
initial values are the same as in Fig. 2 but this time we took σ1 = σ2 = 0.01. These values were recorded at a single
large time t = 9000 days from one thousand different realisations of each of the two stochastic processes. Comparing
these figures we see that the distribution of both the variables x1(t) and z(t) at large times look very similar. The vari-
1100 N. Dalal et al. / J. Math. Anal. Appl. 341 (2008) 1084–1101Fig. 5. Distribution of z(t) at large time t .
ables are distributed around the mean value of λ/δ, the actual value being 107. A two sample Kolmogorov–Smirnov
test for equality of distribution was performed using a 5% significance level and showed that the two distributions
could not be distinguished statistically (test statistic D = 0.033, p-value = 0.6476). We see that if t is large then z(t)
is a good approximation to x1(t) in the situation where x2(t) and x3(t) tend to zero.
8. Conclusions
In this paper, we have considered a stochastic model describing the viral dynamics of HIV-1 infection. We first
proved the positivity of the solutions. Then we looked at the stability aspect of the model. We proved that the numbers
of infected cells and virus particles tended asymptotically to zero exponentially almost surely. We also showed that
x1(t) approached a mean reverting process z(t) in probability. We then supported our analytical results with the help
of simulations.
Most previously studied models of internal HIV dynamics in the literature have used deterministic differential
equation models, ignoring stochastic effects. Perelson et al. [24] assumed that the number of uninfected cells was a
constant and modelled the dynamics of infected cells and infective virus particles. Bonhoeffer et al. [4], Di Mascio
et al. [10] and Nelson and Perelson [21] discuss models similar to our deterministic model, neglecting the term
(1 − γ )βx1(t)x3(t) as an approximation. Di Mascio et al. introduce HAART and Nelson and Perelson introduce
protease inhibitor drug therapy. Tuckwell and Wan [26] discuss and analyse our deterministic model including the
term (1 − γ )βx1(t)x3(t) and obtain equilibrium and stability results.
The only stochastic differential equation model which we are aware of for HIV internal viral dynamics is due to
Tuckwell and Le Corfec [25] who use a stochastic differential equation model. Their model has similarities with ours
but they use two types of infected cells, latently infected cells and actively infected cells. The variance terms are also
different being functionally dependent on the variables. They explore the model using simulation only and do not give
any analytical results.
Our work shows that stochastic differential equations give another option to model viral dynamics. By replicating
the results from the deterministic case [8] and improving some we have shown that the stochastic model as discussed
here adds another dimension to model viral dynamics. It adds a different perspective to this particular problem and
gives researchers a different route which they can take in the future. As most real world problems are not deterministic
including stochastic effects into the model gives us a more realistic way of modelling viral dynamics.
N. Dalal et al. / J. Math. Anal. Appl. 341 (2008) 1084–1101 1101For example using a stochastic model we were able to examine the limiting asymptotic distribution of the number
of uninfected cells, infected cells and infective virus particles and derive an expression for the limiting asymptotic
variance of the distribution of the number of uninfected cells. Stochastic models are more versatile than deterministic
models because they incorporate random effects such as environmental stochasticity and enable us to model quantities
such as probability distributions of variables, probabilities of extinction and variances which are features which cannot
be included in a deterministic model.
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